Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


06.03.2017

1 Acta Biochim Biophys Sin (Shanghai)
1 Actas Urol Esp
1 AJR Am J Roentgenol
1 Am J Ther
2 ANZ J Surg
1 Arch Toxicol
1 Biochem J
1 Biosens Bioelectron
2 BMJ Case Rep
1 Cancers (Basel)
1 Circ J
1 Clin Genitourin Cancer
1 Clin Oncol (R Coll Radiol)
2 Endocr Pathol
1 Eur J Pharm Biopharm
2 Eur Urol
2 Int J Radiat Oncol Biol Phys
1 Intern Med
1 J Korean Med Sci
1 Lab Invest
1 Medicine (Baltimore)
1 Nat Rev Urol
2 Pan Afr Med J
1 Target Oncol
2 Tumour Biol
1 Urol Int
9 Urologiia
1 Zhejiang Da Xue Xue Bao Yi Xue Ban
1 Zhonghua Yi Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Biochim Biophys Sin (Shanghai)

  1. KIM M, Kim YY, Jee HJ, Bae SS, et al
    Akt3 knockdown induces mitochondrial dysfunction in human cancer cells.
    Acta Biochim Biophys Sin (Shanghai). 2016;48:447-53.
    PubMed     Text format     Abstract available


    Actas Urol Esp

  2. COGORNO WASYLKOWSKI L, Rios-Gonzalez E, Linares Espinos E, Leibar Tamayo A, et al
    Indication for early cystectomy in nonmuscle-invasive bladder cancer. Literature review.
    Actas Urol Esp. 2017 Feb 18. pii: S0210-4806(17)30004.
    PubMed     Text format     Abstract available


    AJR Am J Roentgenol

  3. YOSHIDA S, Takahara T, Kwee TC, Waseda Y, et al
    DWI as an Imaging Biomarker for Bladder Cancer.
    AJR Am J Roentgenol. 2017 Feb 28:1-11. doi: 10.2214/AJR.17.17798.
    PubMed     Text format     Abstract available


    Am J Ther

  4. SINGLA M, Shikha D, Lee S, Baumstein D, et al
    Ileal Neobladder With Mucous Plugs as a Cause of Obstructive Acute Kidney Injury Requiring Emergent Hemodialysis.
    Am J Ther. 2016;23:e1099-101.
    PubMed     Text format     Abstract available


    ANZ J Surg

  5. YAO HH, Chu K, Hallot C, Lewin J, et al
    Metachronous primary urothelial carcinoma following small cell carcinoma of the urinary bladder.
    ANZ J Surg. 2017;87.
    PubMed     Text format    

  6. KAHOKEHR A, Glasson J, Studd R
    Surgical waiting time for radical cystectomy: a New Zealand experience.
    ANZ J Surg. 2016;86:1042-1045.
    PubMed     Text format     Abstract available


    Arch Toxicol

  7. RIZOS CV, Kei A, Elisaf MS
    The current role of thiazolidinediones in diabetes management.
    Arch Toxicol. 2016;90:1861-81.
    PubMed     Text format     Abstract available


    Biochem J

  8. ISMAIL AF, Oskay S, Babteen N, De Piano M, et al
    PAK5 mediates cell:cell adhesion integrity via interaction with E-cadherin in bladder cancer cells.
    Biochem J. 2017 Feb 23. pii: BCJ20160875. doi: 10.1042/BCJ20160875.
    PubMed     Text format     Abstract available


    Biosens Bioelectron

  9. OU X, Hong F, Zhang Z, Cheng Y, et al
    A highly sensitive and facile graphene oxide-based nucleic acid probe: Label-free detection of telomerase activity in cancer patient's urine using AIEgens.
    Biosens Bioelectron. 2017;89.
    PubMed     Text format     Abstract available


    BMJ Case Rep

  10. KIM C, Gao J, Shannon VR, Siefker-Radtke A, et al
    Systemic sarcoidosis first manifesting in a tattoo in the setting of immune checkpoint inhibition.
    BMJ Case Rep. 2016;2016.
    PubMed     Text format     Abstract available

  11. HASSAN M, Qureshi A, Nasir H
    Recurrent verrucous carcinoma of the urinary bladder after transurethral resection followed by intravesical mitomycin, and a review of the literature.
    BMJ Case Rep. 2016;2016.
    PubMed     Text format     Abstract available


    Cancers (Basel)

  12. LI P, Chen J, Miyamoto H
    Androgen Receptor Signaling in Bladder Cancer.
    Cancers (Basel). 2017;9.
    PubMed     Text format     Abstract available


    Circ J

  13. YU HT, Kim TH, Uhm JS, Kim JY, et al
    Clinical Significance of Hematuria in Atrial Fibrillation With Oral Anticoagulation Therapy.
    Circ J. 2017;81:158-164.
    PubMed     Text format     Abstract available


    Clin Genitourin Cancer

  14. HENON C, Huillard O, Preta LH, Blanchet B, et al
    Cytidine Deaminase Activity Assessment to Select Perioperative Chemotherapy Regimen in Localized Bladder Cancer.
    Clin Genitourin Cancer. 2017 Feb 1. pii: S1558-7673(17)30033.
    PubMed     Text format    


    Clin Oncol (R Coll Radiol)

  15. SOLANKI AA, Martin B, Korpics M, Small C, et al
    Adjuvant Radiotherapy Use by US Radiation Oncologists After Radical Cystectomy for Muscle-invasive Bladder Cancer.
    Clin Oncol (R Coll Radiol). 2017 Feb 24. pii: S0936-6555(17)30080.
    PubMed     Text format     Abstract available


    Endocr Pathol

  16. GUPTA S, Zhang J, Rivera M, Erickson LA, et al
    Urinary Bladder Paragangliomas: Analysis of Succinate Dehydrogenase and Outcome.
    Endocr Pathol. 2016;27:243-52.
    PubMed     Text format     Abstract available

  17. KOUBA E, Cheng L
    Neuroendocrine Tumors of the Urinary Bladder According to the 2016 World Health Organization Classification: Molecular and Clinical Characteristics.
    Endocr Pathol. 2016;27:188-99.
    PubMed     Text format     Abstract available


    Eur J Pharm Biopharm

  18. APFELTHALER C, Anzengruber M, Gabor F, Wirth M, et al
    Poly - (L) - glutamic acid drug delivery system for the intravesical therapy of bladder cancer using WGA as targeting moiety.
    Eur J Pharm Biopharm. 2017 Feb 22. pii: S0939-6411(16)30583.
    PubMed     Text format     Abstract available


    Eur Urol

  19. COTTE J, Roupret M
    Re: Long-term Oncological Outcomes of an Active Surveillance Program in Recurrent Low Grade Ta Bladder Cancer.
    Eur Urol. 2017 Feb 18. pii: S0302-2838(17)30106.
    PubMed     Text format    

  20. MAY M, Lebentrau S, Brookman-May SD
    Re: Decreased Overall and Bladder Cancer-specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk Analysis.
    Eur Urol. 2017 Feb 20. pii: S0302-2838(17)30107.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  21. THOMPSON C, Joseph N, Sanderson B, Logue J, et al
    Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:732-739.
    PubMed     Text format     Abstract available

  22. REDDY AV, Christodouleas JP, Wu T, Smith ND, et al
    External Validation and Optimization of International Consensus Clinical Target Volumes for Adjuvant Radiation Therapy in Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:740-746.
    PubMed     Text format     Abstract available


    Intern Med

  23. KITAYAMA H, Yokota T, Kondo T, Sugiyama J, et al
    Unusual Development of Pulmonary Tumor Embolism from Controlled Liver Metastases of Transitional Cell Carcinoma: An Autopsy Case.
    Intern Med. 2016;55:2453-6.
    PubMed     Text format     Abstract available


    J Korean Med Sci

  24. PARK SJ, Myung SK, Lee Y, Lee YJ, et al
    Effects of Vitamin and Antioxidant Supplements in Prevention of Bladder Cancer: a Meta-Analysis of Randomized Controlled Trials.
    J Korean Med Sci. 2017;32:628-635.
    PubMed     Text format     Abstract available


    Lab Invest

  25. MIGITA T, Ueda A, Ohishi T, Hatano M, et al
    Epithelial-mesenchymal transition promotes SOX2 and NANOG expression in bladder cancer.
    Lab Invest. 2017 Feb 27. doi: 10.1038/labinvest.2017.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  26. WU YP, Lin TT, Chen SH, Xu N, et al
    Comparison of the efficacy and feasibility of en bloc transurethral resection of bladder tumor versus conventional transurethral resection of bladder tumor: A meta-analysis.
    Medicine (Baltimore). 2016;95:e5372.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  27. KAMAT AM, Colombel M, Sundi D, Lamm D, et al
    BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG.
    Nat Rev Urol. 2017 Feb 21. doi: 10.1038/nrurol.2017.
    PubMed     Text format     Abstract available


    Pan Afr Med J

  28. KEHILA M, Mekni K, Abouda HS, Chtourou M, et al
    [Leiomyoma of the bladder causing the destruction of a kidney].
    Pan Afr Med J. 2016;24:10.
    PubMed     Text format     Abstract available

  29. BAGAYOGO T, Jakhal N, Slaoui A, Ziouziou I, et al
    [Neoplastic Vesico-vaginal Fistula (VVF) secondary to bladder cancer: a rare entity].
    Pan Afr Med J. 2016;25:59.
    PubMed     Text format     Abstract available


    Target Oncol

  30. ISLAM SS, Mokhtari RB, Akbari P, Hatina J, et al
    Simultaneous Targeting of Bladder Tumor Growth, Survival, and Epithelial-to-Mesenchymal Transition with a Novel Therapeutic Combination of Acetazolamide (AZ) and Sulforaphane (SFN).
    Target Oncol. 2016;11:209-27.
    PubMed     Text format     Abstract available


    Tumour Biol

  31. CANDIDO S, Di Maso M, Serraino D, McCubrey JA, et al
    Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder.
    Tumour Biol. 2016;37:9855-63.
    PubMed     Text format     Abstract available

  32. GUO XG, Long JJ
    Cytokeratin-19 fragment in the diagnosis of bladder carcinoma.
    Tumour Biol. 2016;37:14329-14330.
    PubMed     Text format     Abstract available


    Urol Int

  33. NAKAMURA Y, Yoshida S, Tanaka H, Inoue M, et al
    Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection.
    Urol Int. 2017 Mar 1. doi: 10.1159/000456722.
    PubMed     Text format     Abstract available


    Urologiia

  34. MIKHAILENKO DS, Nemtsova MV
    [Point somatic mutations in bladder cancer: key carcinogenesis events, diagnostic markers and therapeutic targets].
    Urologiia. 2016;:100-105.
    PubMed     Text format     Abstract available

  35. GLYBOCHKO PV, Alyaev JG, Potoldykova NV, Polyakovsky KA, et al
    [The role of telomerase activity in non-invasive diagnostics of bladder cancer].
    Urologiia. 2016;:76-81.
    PubMed     Text format     Abstract available

  36. KOSOVA IV
    [The role of viruses in the etiology of bladder cancer].
    Urologiia. 2016;:100-103.
    PubMed     Text format     Abstract available

  37. GLYBOCHKO PV, Alyaev YG, Pshikhachev AM, Sorokin NI, et al
    [Choosing treatment for patients with bladder cancer combined with prostatic hyperplasia].
    Urologiia. 2016;:92-96.
    PubMed     Text format     Abstract available

  38. ROLEVICH AI, Evmenenko AA
    [A systematic review and meta-analysis to assess the recurrence-free survival in non-muscle invasive bladder cancer after transurethral resection guided by 5-aminolevulinic acid-induced photodynamic diagnosis compared with white-light transurethral re
    Urologiia. 2016;:137-146.
    PubMed     Text format     Abstract available

  39. YARMOSHCHUK SV, Kudryavtsev AS, Zeravin AA, Drobyazgin EA, et al
    [Robot-assisted cystprostatectomy for urinary bladder cancer (the first experience)].
    Urologiia. 2016;:132-135.
    PubMed     Text format     Abstract available

  40. PAVLOV VN, Pushkaryev AM, Safiullin RI, Kazikhinurov AA, et al
    [Experience with radical surgery for muscle-invasive bladder cancer in patients with end-stage chronic kidney disease].
    Urologiia. 2016;:124-127.
    PubMed     Text format     Abstract available

  41. ALYAEV YG, Pshikhachev AM, Perekalina AN
    [The risk of bladder cancer in patients with prostatic hyperplasia and strategies to manage this combination].
    Urologiia. 2016;:115-118.
    PubMed     Text format     Abstract available

  42. ROLEVICH AI
    [The criteria of patient selection for repeat transurethral resection of non-muscle invasive bladder cancer].
    Urologiia. 2016;:71-76.
    PubMed     Text format     Abstract available


    Zhejiang Da Xue Xue Bao Yi Xue Ban

  43. FENG S, Chen J, Zheng Y
    [Research progress on the effect of glucocorticoid receptor signaling pathways in bladder cancer].
    Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016;45:655-660.
    PubMed     Text format     Abstract available


    Zhonghua Yi Xue Za Zhi

  44. XING QW, Wu Y, Cai B, Ma LM, et al
    [Clinical research of second resection on early stage primary bladder adenocarcinoma and literature review].
    Zhonghua Yi Xue Za Zhi. 2016;96:1585-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: